New registry to track stem cell treatments for brain inflammation
NCT ID NCT07145502
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study follows 76 people aged 6 to 70 with autoimmune or post-infection brain inflammation who are receiving stem cell or exosome treatments. Researchers will track changes in neurological symptoms, inflammation markers, and quality of life over time. The goal is to understand how well these personalized regenerative therapies work in real-world clinics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biocells Medical
Warsaw, 01-234, Poland
Conditions
Explore the condition pages connected to this study.